Article Text

PDF
Comparing risk behaviours of human papillomavirus-vaccinated and non-vaccinated women
  1. Laura Sadler1,
  2. Stephen A Roberts2,
  3. Gail Hampal3,
  4. Dona McManus4,
  5. Debashis Mandal5,
  6. Loretta Brabin6
  1. 1Research Associate, Institute of Cancer Sciences, University of Manchester, Manchester, UK
  2. 2Senior Lecturer in Medical Statistics, Centre for Biostatistics, University of Manchester, Manchester, UK
  3. 3Sister, Department of Genitourinary Medicine, Warrington and Halton Hospitals NHS Foundation Trust, Cheshire, UK
  4. 4Departmental Manager, Department of Genitourinary Medicine, Warrington and Halton Hospitals NHS Foundation Trust, Cheshire, UK
  5. 5Consultant in Genitourinary Medicine, Department of Genitourinary Medicine, Warrington and Halton Hospitals NHS Foundation Trust, Cheshire, UK and Senior Lecturer, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK
  6. 6Reader in Women's Health, Institute of Cancer Sciences, University of Manchester, Manchester, UK
  1. Correspondence to Dr Laura Sadler, Institute of Cancer Sciences, University of Manchester, Research Floor, Level 5, St Mary's Hospital, Oxford Road, Manchester M13 9WL, UK; laura.sadler{at}manchester.ac.uk

Abstract

Background Since September 2008, a national vaccine programme in the UK has offered routine human papillomavirus (HPV) vaccination to young women aged 12–13 years. A catch-up programme also offered HPV vaccination to women born after 1 September 1990.

Aim To compare indicators of risk and preventive behaviours among young women attending genitourinary medicine (GUM) clinics who had, and had not, received at least one dose of HPV vaccine.

Methods Clinical histories and HPV vaccination status were obtained from 363 participants eligible for HPV vaccination (Cervarix®) in the UK vaccination programme (born after 1 September 1990) attending GUM clinics in the North West of England. Using logistic regression, markers of sexual and non-sexual risk behaviours were compared between vaccinated and unvaccinated women.

Results At least one dose of HPV vaccine had been received by 63.6% (n=231) of participants. Unvaccinated women demonstrated higher levels of risky behaviour than those who had undergone HPV vaccination. Unvaccinated women were significantly more likely to have had three or more partners in the last 6 months, attended the clinic with symptoms, not used a condom at first sexual intercourse, had anal intercourse with their last sexual contact, to have tested positive for Chlamydia trachomatis diagnosis at the clinic visit and to be a current smoker.

Conclusions In the UK, where vaccine coverage is high, failure to initiate HPV vaccination amongst GUM attendees is a marker of high-risk behaviours. As a result, HPV vaccination status should be ascertained as part of an individual's clinical history by sexual health services to ensure advice and counselling is provided to those at greatest risk of HPV-associated disease.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Highlights from this issue
    British Medical Journal Publishing Group